Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant's IDE clinical trial.
Here's what you should know.
1. LifeBond partnered with 20 medical centers to enroll patients into the study.
2. LifeBond will announce an additional 20 clinical sites soon.
3. Several Western European countries commercially use LifeSeal, which earned a CE Mark in April 2016.
4. The gastrointestinal-facing sealant provides reinforcement and minimize staple-line leakage.